Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppression After Kidney Transplantation”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Very early researchLooking for participantsNCT06972069
What this trial is testing

Tolerance Through Mixed Chimerism (Sip-Tego)

Who this might be right for
Kidney FailureTransplant Recipient (Kidney)Transplant Tolerance+2 more
Tatsuo Kawai, MD, PhD 12
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Post-approval studies (Phase 4)UnknownNCT01875224
What this trial is testing

Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

Who this might be right for
New Onset Diabetes After TransplantKidney Transplantation
University of Arizona 32
Testing effectiveness (Phase 2)Study completedNCT00403416
What this trial is testing

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 215
Not applicableStudy completedNCT00364650
What this trial is testing

Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation

Who this might be right for
Immunosuppressant Associated Diarrhea
Swedish Medical Center 44
Large-scale testing (Phase 3)Ended earlyNCT01324934
What this trial is testing

Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids

Who this might be right for
Renal Transplant Rejection
Neovii Biotech 40
Post-approval studies (Phase 4)Study completedNCT01935128
What this trial is testing

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Who this might be right for
Renal Transplant
University of Toledo Health Science Campus 55
Post-approval studies (Phase 4)Study completedNCT00866879
What this trial is testing

Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

Who this might be right for
Renal Transplant Rejection
Northwestern University 275
Testing effectiveness (Phase 2)Study completedNCT00078858
What this trial is testing

Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more
Fred Hutchinson Cancer Center 37
Not applicableStudy completedNCT04189835
What this trial is testing

EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients

Who this might be right for
EBV InfectionEBV ViremiaEpstein-Barr Virus Associated Lymphoproliferative Disorder+1 more
University of Aarhus 509
Early research (Phase 1)UnknownNCT05338177
What this trial is testing

Pilot Trial on Immunosuppression Modulation to Increase SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients

Who this might be right for
COVID-19
Medical University of Vienna 40
Testing effectiveness (Phase 2)Study completedNCT00492869
What this trial is testing

Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 124
Post-approval studies (Phase 4)UnknownNCT02453867
What this trial is testing

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

Who this might be right for
Immunosuppression After Renal Transplantation
Klemens Budde 400
Large-scale testing (Phase 3)Study completedNCT00296348
What this trial is testing

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 198
Post-approval studies (Phase 4)UnknownNCT01550445
What this trial is testing

Steroid Withdrawal Immunosuppression After Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 30
Not applicableUnknownNCT00461357
What this trial is testing

Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program

Who this might be right for
Kidney Function After TransplantationOutcome After Kidney Transplantation
Medical University of Vienna 48
Post-approval studies (Phase 4)Ended earlyNCT00991510
What this trial is testing

Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

Who this might be right for
Stable Renal Transplant Recipients
Teva Branded Pharmaceutical Products R&D, Inc. 43
Large-scale testing (Phase 3)Study completedNCT01011205
What this trial is testing

Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 893
Post-approval studies (Phase 4)Study completedNCT00807144
What this trial is testing

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

Who this might be right for
End-stage Renal FailureGraft Rejection
Imperial College Healthcare NHS Trust 102
Post-approval studies (Phase 4)Ended earlyNCT03689075
What this trial is testing

Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

Who this might be right for
Kidney Transplant FailureAllosensitizationImmunosuppression
Imperial College Healthcare NHS Trust 35
Next Page